Barreto-Andrade et al (31) have noted that PARP inhibition by ABT-888 enhances antitumor effects of radiation in PC-3 prostate tumors but not in DU-145 prostate tumors, despite similar radiation sensitization shown in both cell lines in vitro. The gene discussed is PARP1; the disease is prostate neoplasm.